Protective Effects of Allium senescens Extract against 6-Hydroxydopamine in Neurons
Source abstract
Abstract
Oxidative neurodegeneration causes various neuronal diseases, including Alzheimer’s, Parkinson’s, and Huntington’s diseases. This study aimed to demonstrate the protective effect of Allium senescens leaf extracts on 6-hydroxydopamine (6-OHDA)-stressed SH-SY5Y cells, which are known to be optimal for neurotoxic research. The levels of apoptotic markers were evaluated using quantitative polymerase chain reaction (qPCR) and flow cytometry. The localization of apoptotic cells in vivo was analyzed using whole-mount immunochemistry and terminal deoxynucleotidyl transferase dUTP nick end labeling assay. Additionally, the production of reactive oxygen species (ROS) was estimated using flow cytometry. 6-OHDA induced ROS production in neuroblasts and in vivo, but treatment with the extract protected against the 6-OHDA-induced increase in ROS levels. Under oxidative stress, the extract performs three protective functions: decreasing ROS production, preventing mitochondrial apoptosis, and protecting the central and ventral nervous systems. These results also suggest that the extract can be useful in the development of functional foods for the prevention of neural damage caused by oxidative stress.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Neuroinflammation and Neurodegeneration Mechanisms · Nuclear Receptors and Signaling · Alzheimer's disease research and treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bio-Hemp Technology, Andong Science College, Andong 36616, Republic of Korea
Department of Dental Hygiene, Andong Science College, Andong 36616, Republic of Korea
Biocom, 59-17, Magokjungang-ro, Gangseo-gu, Seoul 07807, Republic of Korea
EVERBIO, 131, Jukhyeon-gil, Gwanghyewon-myeon, Jincheon-gun 27809, Republic of Korea
Funding
EVERBIO
References (35)
Show source-provided references
1. Oxidative stress and neurodegenerative disorders10.1007/BF02255928 ↗
2. Mitochondria dysfunction and neurodegenerative disorders: Cause or consequence10.3233/JAD-2010-100345 ↗
3. Experimental evidence for a toxic etiology of tropical parkinsonism10.1002/mds.20300 ↗
4. β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease10.1126/science.aaf3934 ↗
5. Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: Evidence for de-differentiation of resident astrocytes10.1007/s00441-010-1061-x ↗
6. Kim, G.H., Kim, J.E., Rhie, S.J., and Yoon, S. (2015). The role of oxidative stress in neurodegenerative diseases. Exp. Neurobiol., 24.10.5607/en.2015.24.4.325 ↗
7. Kiran, N.S., Yashaswini, C., Lowkesh, G., Range, K., and Madhu, R. (2024). Phytochemicals and Herbal Medicines: Potential Drug Candidates for Obsessive-Compulsive Disorder Treatment. Nutrition and Obsessive-Compulsive Disorder, CRC Press.10.1201/9781003387893-18 ↗
8. Parkinson disease10.1038/nrdp.2017.13 ↗
9. Use of monoamine oxidase inhibitors in chronic neurodegeneration10.1080/17425255.2017.1273901 ↗
10. Neuroprotective effects of bioavailable polyphenol-derived metabolites against oxidative stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells10.1021/acs.jafc.6b04538 ↗
11. The neonate-6-hydroxydopamine-lesioned rat: A model for clinical neuroscience and neurobiological principles10.1016/j.brainresrev.2004.08.004 ↗
12. The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model
13. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae10.1016/S0301-0082(96)00015-9 ↗
14. Oxidative stress: Apoptosis in neuronal injury10.2174/156720506778249515 ↗
15. Mitochondria: From bioenergetics to the metabolic regulation of carcinogenesis10.2741/3509 ↗
16. Monoamine oxidases, oxidative stress, and altered mitochondrial dynamics in cardiac ageing10.1155/2017/3017947 ↗
17. Mitochondrial regulation of apoptosis10.1152/nips.01433.2002 ↗
18. Cytokine response modifier a inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer10.1074/jbc.M605151200 ↗
19. Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP10.1021/cb3005512 ↗
20. Kvansakul, M., Caria, S., and Hinds, M.G. (2017). The Bcl-2 family in host-virus interactions. Viruses, 9.10.3390/v9100290 ↗
21. Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloid-β precursor protein and amyloidogenic Aβ peptide formation10.1016/S0092-8674(00)80748-5 ↗
22. Ethnobotany of the wild edible plants gathered in Ulleung Island, South Korea10.1007/s10722-015-0257-z ↗
23. Allicin and alliin content and antifungal activity of Allium senescens L. ssp. montanum (FW Schmidt) Holub ethanol extract
24. Anti-hepatofibrosis effect of Allium senescens in activated hepatic stellate cells and thioacetamide-induced fibrosis rat model10.1080/13880209.2018.1529801 ↗
25. Chemical constituents of three Allium species from Romania10.3390/molecules18010114 ↗
26. The role of mitochondrial ROS in the aging brain10.1002/1873-3468.12902 ↗
27. Alfadda, A.A., and Sallam, R.M. (2012). Reactive oxygen species in health and disease. BioMed Res. Int., 2012.10.1155/2012/936486 ↗
28. In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer’s disease, Parkinson’s disease, and diabetes10.1080/10715762.2017.1315114 ↗
29. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis10.1016/j.cell.2005.05.011 ↗
30. Nuclear factor-kappa β as a therapeutic target for Alzheimer’s disease10.1111/jnc.14687 ↗
31. Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway10.1016/j.biopha.2018.11.108 ↗
32. Kim, B.Y., Shin, G.H., Lee, I.S., Kim, S.W., Kim, H.S., Kim, J.K., and Lee, S.G. (2017). Localization patterns of dopamine active transporter synthesizing cells during development of brine shrimp. Arch. Insect Biochem. Physiol., 94.10.1002/arch.21378 ↗
33. Distinctive localization of Group 3 late embryogenesis abundant synthesizing cells during brine shrimp development10.1002/arch.21234 ↗
34. Toxic effects of two commercial polybrominated diphenyl ethers on Artemia larvae at three developmental stages10.1163/15685403-bja10042 ↗
35. Multisensory convergence in the mushroom bodies of ants and bees10.1556/ABiol.55.2004.1-4.5 ↗